>Am 6. Januar 2015 hat Deep Blue den PCT-Produktregistrierungsantrag erfolgreich bestanden;
.................................................... .................................................... ................................
> Am 5. Mai 2016 bestand das Human-Choriongonadotropin-Testpapier von Deep Blue Medical die Stichprobeninspektion durch die Anhui Food and Drug Administration;
.................................................... .................................................... ................................
Adresse
Pearl Industrial Park,106 Innovation Avenue, High-Tech Development Zone / No. 777 Jimingshan Road, High-Tech Development Zone, 230088 Hefei, Anhui, PEOPLE'S REPUBLIC OF CHINA
